HIV and AIDS Trial, Recruiting (NCT06370780)

HIV and AIDS Trial, Recruiting NCT06370780 Sponsor: University of California, Los Angeles Condition: HIV and AIDS

Printed from Voxsanity (voxsanity.com.au) — NCT06370780 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Hiv Aids

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who own and have access to a personal smartphone
People who are 18 years of age or older
People who speak English or Spanish
People who are living with HIV
People who either are not currently keeping their HIV virus levels low (virally suppressed), are not currently receiving regular HIV medical care, or have a history of missed medical appointments or difficulty keeping virus levels low
People who have an active substance use or mental health condition
People who are willing and able to sign a written consent form to take part in the study

Who may not be able to join:

People who are unwilling or unable to provide reliable contact information
People who are unwilling to provide a blood sample for HIV virus level testing
People living with HIV whose virus levels are already well controlled and who are not considered at risk of losing that control in the near future

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Pamina Gorbach, DrPh, University of California, Los Angeles

Phone: (628) 226-1863

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06370780

Sponsor: University of California, Los Angeles

Phase: Not Applicable

Status: Recruiting

Condition: HIV and AIDS

Trial contact: (628) 226-1863

More information: https://clinicaltrials.gov/study/NCT06370780

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who own and have access to a personal smartphone
People who are 18 years of age or older
People who speak English or Spanish
People who are living with HIV
People who either are not currently keeping their HIV virus levels low (virally suppressed), are not currently receiving regular HIV medical care, or have a history of missed medical appointments or difficulty keeping virus levels low
People who have an active substance use or mental health condition
People who are willing and able to sign a written consent form to take part in the study

Who may not be able to join:

People who are unwilling or unable to provide reliable contact information
People who are unwilling to provide a blood sample for HIV virus level testing
People living with HIV whose virus levels are already well controlled and who are not considered at risk of losing that control in the near future

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of California, Los Angeles

Registry

ClinicalTrials.gov

Start date

9 February 2024

Est. completion

30 April 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Incidence of HIV Viral Suppression; Level of Adherence to HIV medication; Level of Adherence based on HIV appointments

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov